Corporate Strategy
What makes us different?
Capstone combines unparalleled policy analysis and investment acumen that uniquely positions us to advise corporate clients in highly regulated industries. Our core policy analysis capabilities allow us to create value and revenue-driving growth strategies, whether organic or acquisition-focused. We provide corporate clients with real-time and forward-looking policy analyses of legislative and executive branch actions that present new opportunities or to avoid hidden challenges. With our broad range of due diligence capabilities, our unique and varied public policy and industry relationships, and our propensity to go deeper in the weeds than anyone else, we are an ideal partner to help you solve complex policy and regulatory challenges.
We Predict Policy,
Quantify Impact,
and Create Strategy.
Our team of policy and investment analysts leverage our deep and diverse policy subject matter expertise and our relationships with industry groups, regulators, policymakers, and third-party advocates to analyze the risk profile of corporate strategies and potential investments and create actionable best practices to mitigate hidden risk and find novel opportunities.
Capital and Corporate Strategy
- Advise clients on transactions in highly regulated industries
- Provide revenue-driving policy-driven strategy Â
- Idea-driven C-Suite advisory
- Industry analysis
- Consumer patterns and concerns
Policy and Political Analysis
- Provide access for corporate leadership to global senior policymakers.
- Provide real-time analysis of key political and policy changes with detailed analysis of industry impact
- International regulatory agency analysis and risk analysis
- Political risk audits
- Geopolitical risk analysis and sanctions review
Case Studies
Capstone has a proven track record of providing in-depth analysis across a wide range of policy and regulatory issues. Our case studies demonstrate our ability to help clients navigate complex policy challenges and develop targeted revenue-driving strategies.
 Contact Us
Our Latest Insights
US-India Relations Hit a Roadblock (Again)
August 6, 2025 By Alexander Slater, Managing Director American investors and companies that are looking at India as their next big opportunity or an alternative supply chain node to China, as well as Indian companies seeking to enter or expand their footprint in the...
The 340B Dilemma: The Power of Vague Law
July 21, 2025 By Angela Lamari, Capstone Healthcare analyst At only eight and a half pages of statute, the federal 340B drug pricing program is a clear example of how industry speaks when the law is silent. The program itself is fairly simple—in 1992, the government...
What Comes Next After the US Strikes on Iran?Â
July 8, 2025 By Daniel Silverberg and Elena McGovern, Co-Heads of Capstone’s National Security Practice With direct military confrontation among the US, Israel and Iran de-escalated—for now—Capstone is tracking three key questions on behalf of clients: 1. Did...
